Female sexual dysfunction (FSD) is a significant public health problem. We assessed the prevalence of FSD in premenopausal women with the metabolic syndrome as compared to the general female population. Compared with the control group (N¼80), women with the metabolic syndrome (N¼120) had reduced mean full Female Sexual Function Index (FSFI) score (23.275.4 vs 30.174.7, Po0.001), reduced satisfaction rate (3.571.1 vs 4.771.2, Po0.01), and higher circulating levels of C-reactive protein (CRP: 2.2 (0.6/4.9) vs 0.8 (0.2/2.9)mg/l, median (interquartile range), P¼0.01). There was an inverse relation between CRP levels and FSFI score (r¼0.32, P¼0.02). Investigation of female sexuality is suggested for patients with the metabolic syndrome.
The metabolic syndrome: a cause of sexual dysfunction in women
ESPOSITO, Katherine;MARFELLA, Raffaele;COBELLIS, Luigi;GIUGLIANO, Dario
2005
Abstract
Female sexual dysfunction (FSD) is a significant public health problem. We assessed the prevalence of FSD in premenopausal women with the metabolic syndrome as compared to the general female population. Compared with the control group (N¼80), women with the metabolic syndrome (N¼120) had reduced mean full Female Sexual Function Index (FSFI) score (23.275.4 vs 30.174.7, Po0.001), reduced satisfaction rate (3.571.1 vs 4.771.2, Po0.01), and higher circulating levels of C-reactive protein (CRP: 2.2 (0.6/4.9) vs 0.8 (0.2/2.9)mg/l, median (interquartile range), P¼0.01). There was an inverse relation between CRP levels and FSFI score (r¼0.32, P¼0.02). Investigation of female sexuality is suggested for patients with the metabolic syndrome.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
